NEW YORK, June 10 (GenomeWeb News) - ChondroGene has partnered with a pair of hospitals in Malaysia to develop a suite of molecular diagnostics for certain diseases based on its Sentinel Principle technology, the company said today.
As part of the alliance, Lam Wah EE Hospital and
ChondroGene, based in
The hospitals said they would offer ChondroGene's tests to their patients as the diagnostics become available.
K. Wayne Marshall, president and CEO of ChondroGene, said he "expect[s] to enter into similar relationships with other organizations around the world in the future in order to further expand the genetic diversity of our gene expression database. ..."